+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027) - Product Thumbnail Image

Global Glucagon-like Peptide 1 (GLP-1) Market (by Product, Route of Administration, & Region): Insights and Forecast with Potential Impact of COVID-19 (2022-2027)

  • Report
  • November 2023
  • 127 Pages
  • Global
From
Glucagon-like Peptide 1 Global Market Report 2024 - Product Thumbnail Image

Glucagon-like Peptide 1 Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Glucagon-Like Peptide 1 Agonists Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • January 2024
  • 150 Pages
  • Global
From
Glucagon-Like Peptide-1 (GLP-1) Agonists Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028) - Product Thumbnail Image

Glucagon-Like Peptide-1 (GLP-1) Agonists Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

  • Report
  • August 2023
  • 110 Pages
  • Global
From
Middle East And Africa Glucagon-Like Peptide-1 (GLP-1) Agonists Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028) - Product Thumbnail Image

Middle East And Africa Glucagon-Like Peptide-1 (GLP-1) Agonists Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

  • Report
  • August 2023
  • 80 Pages
  • Middle East, Africa
From
Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country: Market Insights and Forecast (2020-2030) - Product Thumbnail Image

Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type, End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country: Market Insights and Forecast (2020-2030)

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Glucagon-like Peptide-1 (GLP-1) Agonists Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2024
  • 120 Pages
  • Global
From
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 100 Pages
  • Global
From
Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 100 Pages
  • Asia Pacific
From
North America Glucagon-like Peptide-1 Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

North America Glucagon-like Peptide-1 Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 80 Pages
  • North America
From
Latin America Glucagon-like Peptide-1 (GLP-1) Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Latin America Glucagon-like Peptide-1 (GLP-1) Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 70 Pages
  • Latin America
From
Europe Glucagon-Like Peptide-1 (GLP-1) Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Europe Glucagon-Like Peptide-1 (GLP-1) Agonists - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 80 Pages
  • Europe
From
Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 181 Pages
  • Europe
From
Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • December 2023
  • 230 Pages
  • Global
From
Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Global Prediabetes Market Size, Share & Trends Analysis Report by Drug Class (Diguanide, Thiazolidinediones), Age Group (Children, Adult), Region, and Segment Forecasts, 2024-2030

  • Report
  • March 2024
  • 134 Pages
  • Global
From
Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis - Product Thumbnail Image

Diabetes Drugs Market, Size, Global Forecast 2023-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

  • Report
  • July 2023
  • 220 Pages
  • Global
From
Global Thyroid Gland Disorders Treatment Market Analysis & Forecast to 2023-2033: Market By Indication; By Route of Administration; By Distribution Channel; and by Region - Product Thumbnail Image

Global Thyroid Gland Disorders Treatment Market Analysis & Forecast to 2023-2033: Market By Indication; By Route of Administration; By Distribution Channel; and by Region

  • Report
  • July 2023
  • 145 Pages
  • Global
From
Global Oral Anti-Diabetic Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Global Oral Anti-Diabetic Drugs Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 177 Pages
  • Global
From
Diabetes Drug Intelligence Center 2012-2023 - Product Thumbnail Image

Diabetes Drug Intelligence Center 2012-2023

  • Report
  • April 2024
  • Global
From
Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029 - Product Thumbnail Image

Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

  • Report
  • February 2024
  • 150 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more